Boston Financial Mangement LLC Sells 10,809 Shares of CME Group Inc. (NASDAQ:CME)

Boston Financial Mangement LLC cut its stake in shares of CME Group Inc. (NASDAQ:CME) by 3.7% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 282,363 shares of the financial services provider’s stock after selling 10,809 shares during the quarter. CME Group makes up approximately 1.9% of Boston Financial Mangement LLC’s holdings, making the stock its 12th biggest position. Boston Financial Mangement LLC owned about 0.08% of CME Group worth $62,303,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Oak Harvest Investment Services lifted its position in shares of CME Group by 66.5% in the first quarter. Oak Harvest Investment Services now owns 45,093 shares of the financial services provider’s stock valued at $9,708,000 after acquiring an additional 18,017 shares in the last quarter. Wealth Enhancement Advisory Services LLC boosted its stake in CME Group by 21.2% in the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 48,205 shares of the financial services provider’s stock worth $9,477,000 after purchasing an additional 8,443 shares during the period. Duality Advisers LP purchased a new stake in CME Group during the 1st quarter valued at approximately $1,455,000. SG Americas Securities LLC grew its holdings in CME Group by 312.2% during the 1st quarter. SG Americas Securities LLC now owns 56,768 shares of the financial services provider’s stock valued at $12,222,000 after buying an additional 42,996 shares in the last quarter. Finally, Cetera Investment Advisers raised its position in shares of CME Group by 429.1% during the first quarter. Cetera Investment Advisers now owns 47,521 shares of the financial services provider’s stock valued at $10,231,000 after buying an additional 38,540 shares during the last quarter. 87.75% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research firms recently weighed in on CME. Barclays raised their target price on shares of CME Group from $219.00 to $231.00 and gave the company an “equal weight” rating in a research note on Thursday, October 24th. Redburn Atlantic cut CME Group from a “buy” rating to a “neutral” rating and set a $244.00 target price on the stock. in a report on Tuesday, October 8th. Citigroup boosted their target price on CME Group from $250.00 to $255.00 and gave the stock a “buy” rating in a research report on Thursday, October 24th. Piper Sandler raised their price target on CME Group from $240.00 to $250.00 and gave the company an “overweight” rating in a report on Monday. Finally, Bank of America upped their price objective on CME Group from $177.00 to $180.00 and gave the stock an “underperform” rating in a report on Thursday, October 3rd. Four equities research analysts have rated the stock with a sell rating, seven have given a hold rating and four have given a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $222.73.

CME Group Trading Up 0.9 %

CME opened at $228.12 on Tuesday. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.02. The stock’s 50 day moving average price is $219.32 and its 200-day moving average price is $208.98. CME Group Inc. has a one year low of $190.70 and a one year high of $230.36. The stock has a market cap of $82.14 billion, a price-to-earnings ratio of 25.95, a P/E/G ratio of 7.76 and a beta of 0.55.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, topping analysts’ consensus estimates of $2.65 by $0.03. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The business had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.59 billion. During the same quarter last year, the firm posted $2.25 earnings per share. The business’s revenue was up 18.4% compared to the same quarter last year. On average, equities analysts forecast that CME Group Inc. will post 10.04 EPS for the current year.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, September 25th. Investors of record on Monday, September 9th were issued a dividend of $1.15 per share. The ex-dividend date was Monday, September 9th. This represents a $4.60 dividend on an annualized basis and a yield of 2.02%. CME Group’s payout ratio is 52.33%.

Insider Buying and Selling at CME Group

In other news, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the transaction, the director now directly owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In other news, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the transaction, the director now owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Lynne Fitzpatrick sold 754 shares of CME Group stock in a transaction dated Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the sale, the chief financial officer now owns 13,261 shares of the company’s stock, valued at $2,877,504.39. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.30% of the stock is owned by corporate insiders.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.